Prelude Therapeutics Inc SEC filings PRLD
Prelude Therapeutics Inc has 389 filings in SEC EDGAR's recent list, going back to Jul 11, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 21, 2026 | Apr 20, 2026 |
| 424B5 | Prospectus supplement | Apr 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Other events
|
Mar 12, 2026 | Mar 12, 2026 |
| 424B5 | Prospectus supplement | Mar 12, 2026 | — |
| S-8 | Employee stock plan registration | Mar 10, 2026 | — |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| EFFECT | Filing | Dec 16, 2025 | — |
| CORRESP | Letter to the SEC | Dec 15, 2025 | — |
| S-3 | Shelf registration | Dec 10, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Nov 4, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 17, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Other events
|
Sep 19, 2025 | Sep 18, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
Apr 25, 2025 | Apr 25, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 28, 2025 | Mar 27, 2025 |
| S-8 | Employee stock plan registration | Mar 10, 2025 | — |
| 10-K | Annual report | Mar 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Other events
|
Dec 11, 2024 | Dec 11, 2024 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Other events
|
Sep 13, 2024 | Sep 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2024 | Jun 12, 2024 |
| EFFECT | Filing | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2024 | — |
| S-3 | Shelf registration | May 30, 2024 | — |
| 8-K/A |
Amended current report
Officer or director change
|
May 16, 2024 | Apr 8, 2024 |
| EFFECT | Filing | May 8, 2024 | — |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| CORRESP | Letter to the SEC | May 6, 2024 | — |
| S-3/A | Filing | May 6, 2024 | — |
| CORRESP | Letter to the SEC | May 3, 2024 | — |
| CORRESP | Letter to the SEC | May 1, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2024 | Apr 8, 2024 |
| UPLOAD | Letter from the SEC | Feb 21, 2024 | — |
| S-3 | Shelf registration | Feb 16, 2024 | — |
| S-8 | Employee stock plan registration | Feb 16, 2024 | — |
| 10-K | Annual report | Feb 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 1, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2023 | Nov 1, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2023 | Jun 1, 2023 |
| 424B5 | Prospectus supplement | May 19, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 19, 2023 | May 18, 2023 |
| FWP | Free writing prospectus | May 18, 2023 | — |
| 424B5 | Prospectus supplement | May 17, 2023 | — |
| 8-K |
Current report
Other events
|
May 17, 2023 | May 17, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2023 | May 8, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 16, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 15, 2023 | Mar 15, 2023 |
| 424B5 | Prospectus supplement | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 23, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 17, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 17, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 6, 2022 |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 10-K | Annual report | Mar 17, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2022 | Mar 16, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 9, 2022 | Mar 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2022 | Feb 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 3, 2021 | Nov 30, 2021 |
| EFFECT | Filing | Nov 24, 2021 | — |
| CORRESP | Letter to the SEC | Nov 22, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2021 | — |
| S-3 | Shelf registration | Nov 12, 2021 | — |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 12, 2021 | Nov 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2021 | Jul 15, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2021 | May 12, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2021 | Mar 17, 2021 |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| 10-K | Annual report | Mar 16, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2021 | Jan 22, 2021 |
| 424B4 | Prospectus | Jan 7, 2021 | — |
| EFFECT | Filing | Jan 6, 2021 | — |
| S-1MEF | Filing | Jan 6, 2021 | — |
| CORRESP | Letter to the SEC | Jan 4, 2021 | — |
| CORRESP | Letter to the SEC | Jan 4, 2021 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 4, 2021 | Jan 4, 2021 |
| S-1 | Registration statement | Jan 4, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2020 | — |
| DRS | Filing | Dec 21, 2020 | — |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement
|
Nov 4, 2020 | Nov 1, 2020 |
| 424B4 | Prospectus | Sep 25, 2020 | — |
| S-8 | Employee stock plan registration | Sep 25, 2020 | — |
| EFFECT | Filing | Sep 24, 2020 | — |
| CERT | Filing | Sep 24, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| S-1/A | Amended registration statement | Sep 21, 2020 | — |
| 8-A12B | Filing | Sep 16, 2020 | — |
| CORRESP | Letter to the SEC | Sep 16, 2020 | — |
| S-1/A | Amended registration statement | Sep 16, 2020 | — |
| CORRESP | Letter to the SEC | Sep 9, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2020 | — |
| S-1 | Registration statement | Sep 4, 2020 | — |
| D | Filing | Aug 28, 2020 | — |
| DRSLTR | Filing | Aug 26, 2020 | — |
| DRS/A | Filing | Aug 26, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2020 | — |
| DRS | Filing | Jul 23, 2020 | — |
| D | Filing | Jun 17, 2019 | — |
| D/A | Filing | Aug 17, 2018 | — |
| D | Filing | Oct 20, 2017 | — |
| D | Filing | Jul 11, 2016 | — |
Showing 173 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRLD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1678660
- Former names
- Prelude Therapeutics Inc. (until Oct 20, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.